XFRA ISIN CHANGE

Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA09226M1005 Black Swan Graphene Inc. 07.02.2025 CA09226M2094 Black Swan Graphene Inc. 10.02.2025 Tausch 8:1
CA17040T3001 Chorus Aviation Inc. 07.02.2025 CA17040T8885 Chorus Aviation Inc. 10.02.2025 Tausch 7:1
IT0001350625 Olidata S.p.A. 07.02.2025 IT0005634610 Olidata S.p.A. 10.02.2025 Tausch 10:1
US09075P1057 BioXcel Therapeutics Inc. 07.02.2025 US09075P2048 BioXcel Therapeutics Inc. 10.02.2025 Tausch 16:1
US87807D5095 TC BioPharm (Holdings) PLC 07.02.2025 US87807D6085 TC BioPharm (Holdings) PLC 10.02.2025 Tausch 20:1
US33817P3064 FitLife Brands Inc. 07.02.2025 US33817P4054 FitLife Brands Inc. 10.02.2025 Tausch 1:2

Zeit	Aktuelle Nachrichten
Di	BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia	Topline data expected in second half of 2025 to support potential sNDA submission for label expansion of IGALMI® in the home setting Company has $35M of cash following closing of recent equity financing... ► Artikel lesen
So	Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week
07.03.	BioXcel Therapeutics erreicht 33% Rekrutierung in klinischer Studie
07.03.	BioXcel Therapeutics reaches 33% enrollment in trial
07.03.	BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia	Data to support potential sNDA submission for label expansion of IGALMI® in the home setting Topline data expected in second half of 2025 NEW HAVEN, Conn., March 07, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen

Zeit

Aktuelle Nachrichten

BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Topline data expected in second half of 2025 to support potential sNDA submission for label expansion of IGALMI® in the home setting Company has $35M of cash following closing of recent equity financing...
► Artikel lesen

Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week

07.03.

BioXcel Therapeutics erreicht 33% Rekrutierung in klinischer Studie

07.03.

BioXcel Therapeutics reaches 33% enrollment in trial

07.03.

BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Data to support potential sNDA submission for label expansion of IGALMI® in the home setting Topline data expected in second half of 2025 NEW HAVEN, Conn., March 07, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen

Zeit	Aktuelle Nachrichten
25.02.	Black Swan Graphene Inc (2): Black Swan appoints Roadcap as head of technical sales
25.02.	Black Swan Graphene Inc.: Black Swan Graphene Announces the Appointment of Industry Veteran Dan Roadcap as Head of Technical Sales and Business Development	Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R960) ("Black Swan" or the "Company") is pleased to announce the strategic appointment... ► Artikel lesen
21.02.	Black Swan Graphene Inc (2): Black Swan hires Capital Analytica for IR services
21.02.	Black Swan Graphene Inc.: Black Swan Graphene Retains Public Awareness Consultant and Announces Grant of Stock Options and Restricted Share Units	Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R96) ("Black Swan" or the "Company") is pleased to announce it has entered into an... ► Artikel lesen
12.02.	Black Swan Graphene Inc (2): Black Swan Graphene closes $6-million private placement

Zeit

Aktuelle Nachrichten

25.02.

Black Swan Graphene Inc (2): Black Swan appoints Roadcap as head of technical sales

25.02.

Black Swan Graphene Inc.: Black Swan Graphene Announces the Appointment of Industry Veteran Dan Roadcap as Head of Technical Sales and Business Development

Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R960) ("Black Swan" or the "Company") is pleased to announce the strategic appointment...
► Artikel lesen

21.02.

Black Swan Graphene Inc (2): Black Swan hires Capital Analytica for IR services

21.02.

Black Swan Graphene Inc.: Black Swan Graphene Retains Public Awareness Consultant and Announces Grant of Stock Options and Restricted Share Units

Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQB: BSWGF) (FSE: R96) ("Black Swan" or the "Company") is pleased to announce it has entered into an...
► Artikel lesen

12.02.

Black Swan Graphene Inc (2): Black Swan Graphene closes $6-million private placement

Zeit	Aktuelle Nachrichten
21.02.	Chorus Aviation stock upgraded, target raised to Cdn$27 at TD Securities
21.02.	Chorus Aviation Non-GAAP EPS of C$0.39, revenue of C$353.16M; initiates FY outlook
21.02.	Chorus Aviation verzeichnet signifikanten Verlust im letzten Quartal
20.02.	Chorus Aviation Inc. Announces Fourth Quarter and Year-end 2024 Financial Results
10.02.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025	The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2... ► Artikel lesen

Zeit

Aktuelle Nachrichten

21.02.

Chorus Aviation stock upgraded, target raised to Cdn$27 at TD Securities

21.02.

Chorus Aviation Non-GAAP EPS of C$0.39, revenue of C$353.16M; initiates FY outlook

21.02.

Chorus Aviation verzeichnet signifikanten Verlust im letzten Quartal

20.02.

Chorus Aviation Inc. Announces Fourth Quarter and Year-end 2024 Financial Results

10.02.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025

The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	FITLIFE BRANDS, INC. - 8-K, Current Report
07.03.	FitLife Brands, Inc.: FitLife Brands Announces Fourth Quarter Earnings Call
10.02.	XFRA QO80: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFITLIFE BRANDS INC.... ► Artikel lesen
10.02.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025	The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2... ► Artikel lesen
07.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025	The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025ISIN NameCA09226M1005 BLACK... ► Artikel lesen

Zeit

Aktuelle Nachrichten

FITLIFE BRANDS, INC. - 8-K, Current Report

07.03.

FitLife Brands, Inc.: FitLife Brands Announces Fourth Quarter Earnings Call

10.02.

XFRA QO80: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFITLIFE BRANDS INC....
► Artikel lesen

10.02.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025

07.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025

The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025ISIN NameCA09226M1005 BLACK...
► Artikel lesen

Zeit	Aktuelle Nachrichten
10.02.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025	The following instruments on XETRA do have their first trading 10.02.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2025 Aktien 1 SE0023615638 Asmodee Group AB 2... ► Artikel lesen
07.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025	The following instruments on Boerse Frankfurt do have their last trading day on 07.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 07.02.2025ISIN NameCA09226M1005 BLACK... ► Artikel lesen
07.02.	XFRA ISIN CHANGE	Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA09226M1005 Black Swan Graphene Inc. 07.02.2025 CA09226M2094 Black Swan Graphene Inc. 10.02.2025 Tausch 8:1CA17040T3001 Chorus... ► Artikel lesen
07.02.	XFRA CAPITAL ADJUSTMENT INFORMATION - 07.02.2025	Das Instrument PQ51 CA6993202069 PARAMOUNT RES LTD CLASS A EQUITY wird cum Kapitalmassnahme gehandelt am 07.02.2025 und ex Kapitalmassnahme am 10.02.2025 The instrument PQ51 CA6993202069 PARAMOUNT RES... ► Artikel lesen

Zeit

Aktuelle Nachrichten

10.02.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 10.02.2025

07.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 07.02.2025

07.02.

XFRA ISIN CHANGE

07.02.

XFRA CAPITAL ADJUSTMENT INFORMATION - 07.02.2025

Das Instrument PQ51 CA6993202069 PARAMOUNT RES LTD CLASS A EQUITY wird cum Kapitalmassnahme gehandelt am 07.02.2025 und ex Kapitalmassnahme am 10.02.2025 The instrument PQ51 CA6993202069 PARAMOUNT RES...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06.03.	TC BioPharm signs LoI to acquire ophthalmic pharma company
05.03.	TC BioPharm executes LOI to acquire ophthalmic pharma firm
05.03.	TC BioPharm: TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company	FDA-approved product in a multi-billion-dollar market Revenue generation projected in 2025 EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm... ► Artikel lesen
13.02.	TC BioPharm: TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial	No adverse events related to TCB008 have occurred Evidence of stable disease following TCB008 infusion EDINBURGH, Scotland, Feb. 13, 2025 /PRNewswire/ --... ► Artikel lesen
10.02.	TC BioPharm plc - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

06.03.

TC BioPharm signs LoI to acquire ophthalmic pharma company

05.03.

TC BioPharm executes LOI to acquire ophthalmic pharma firm

05.03.

TC BioPharm: TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

FDA-approved product in a multi-billion-dollar market Revenue generation projected in 2025 EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm...
► Artikel lesen

13.02.

TC BioPharm: TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

No adverse events related to TCB008 have occurred Evidence of stable disease following TCB008 infusion EDINBURGH, Scotland, Feb. 13, 2025 /PRNewswire/ --...
► Artikel lesen

10.02.

TC BioPharm plc - 6-K, Report of foreign issuer

Unternehmen / Aktien	Kurs	%
BIOXCEL THERAPEUTICS INC	2,950	-100,00 %
BLACK SWAN GRAPHENE INC	0,526	-4,19 %
CHORUS AVIATION INC	12,880	-0,62 %
FITLIFE BRANDS INC	6,250	0,00 %
OLIDATA SPA	1,850	+0,65 %
TC BIOPHARM HOLDINGS PLC ADR	1,670	0,00 %

Unternehmen / Aktien

Kurs

BIOXCEL THERAPEUTICS INC

2,950

-100,00 %

BLACK SWAN GRAPHENE INC

0,526

-4,19 %

CHORUS AVIATION INC

12,880

-0,62 %

FITLIFE BRANDS INC